Quality Assessment of Systematic Reviews of Health Economic Evaluations: Pitfalls with the Application of the PRISMA Statement. Comment on Quang et al. (Sys Rev Pharm. 2017;8(1):52-61)
In a recently published article, Quang et al. evaluate the quality of systematic reviews of health economic evaluations of interventions for hepatitis.1 As the authors of one of the systematic reviews included in the assessment,2 we would like to discuss the methods which were applied and which, in our opinion, seem to be inappropriate.